Bank of America Predicts Massive Surge for These Two High-Potential Biotech Stocks
Bank of America foresees a large increase in two high-potential biotech stocks, aided by a cooling economy that reduces inflation concerns and drives the S&P 500 to new highs
Annual Investment Meeting launch Arab China Unicorn Investment Conclave
The 12th edition of The Annual Investment Meeting (AIM) hosted the China Top 50 Unicorns. The event took place at the Innovation and Technology Track located at the Abu Dhabi National Exhibition Centre, and brought together investors, startups, and innovators from the UAE and China.
Growth stock comeback fuels Cathie Wood’s ARK funds
A more than 10% surge in growth stocks since the start of the quarter is fueling a comeback in star stock picker Cathie Wood’s ARK funds, which posted some of the worst declines among all U.S. equity funds over the first three months of the year.
Danish ‘meme stock’ Orphazyme plunges after drug setback
Orphazyme (ORPHA.CO) slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate, sending shares in Denmark’s first so-called meme stock tumbling 75% in early trading.
‘Meme stock’ rally pauses, Redditors focus on biotech stocks
Small-time stock traders turned their attention to the biotech and healthcare sectors on Monday, lifting shares of some by as much as 10%, while the rally in stocks that were favored in recent weeks appeared to fade.
Big Biogen boost on Alzheimer’s news could win back biotech investors
The approval by U.S. regulators on Monday of a Biogen Inc (BIIB.O) drug to treat Alzheimer’s disease could reinvigorate investor interest more broadly in biotech and pharmaceutical shares that have struggled in 2021.
